Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

EXCLUSIVE: Hoth Therapeutics Announces Results In Cohort 1 Of Human Clinical Trial Of BioLexa In Eczema; Says No Serious Adverse Events And No Drug-Related Treatment-Emergent Adverse Events Observed

NEW YORK, NY, September 8, 2021 /PRNewswire/ Today, Hoth Therapeutics, Inc. (NASDAQ:HOTH), a patient focused biopharmaceutical company, announced the completed safety results in Cohort 1 of its first in human clinical

HOTH

Read More

EXCLUSIVE: Alfi CEO Responds To Short Report By Bleecker Street, Tells Benzinga Co.’s Platform Uses No Cookies, Is Privacy Compliant, Collects No Personal User Data

Full comment from CEO Paul Pereira: "Alfi bought back as stated $2 mm of their shares. Alfi has a ground breaking technology with a solid leadership team. Alfi platform uses no cookies, is privacy compliant and collects no personal user information Alfi is the next generation disruptive platform in the digital world and will never always deliver content in an ethical and respectful manner.

ALF